CPI-006
CPI-006-002
Phase 1 small_molecule completed
Quick answer
CPI-006 for COVID-19 is a Phase 1 program (small_molecule) at Corvus Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Corvus Pharmaceuticals
- Indication
- COVID-19
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed